51 – 60 of 64
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2003
-
Mark
Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies
(
- Contribution to journal › Article
- 2002
-
Mark
Discrimination of benign from malignant prostatic disease by selective measurements of single chain, intact free prostate specific antigen
(
- Contribution to journal › Article
-
Mark
MRI-guided thermal therapy of transplanted tumors in the canine prostate using a directional transurethral ultrasound applicator
(
- Contribution to journal › Article
- 2000
-
Mark
Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer
(
- Contribution to journal › Article
- 1999
-
Mark
Significance and metabolism of complexed and noncomplexed prostate specific antigen forms, and human glandular kallikrein 2 in clinically localized prostate cancer before and after radical prostatectomy
(
- Contribution to journal › Article
-
Mark
CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk
(
- Contribution to journal › Article
-
Mark
Familial and hereditary prostate cancer in southern Sweden. A population-based case-control study
(
- Contribution to journal › Article
-
Mark
Cancer risks in BRCA2 mutation carriers
(
- Contribution to journal › Article
- 1998
-
Mark
Clinical course of early onset prostate cancer with special reference to family history as a prognostic factor
(
- Contribution to journal › Article
-
Mark
Forskningsframsteg om hereditär prostatacancer. Riskfamiljer bör kartläggas och erbjudas screening
(
- Contribution to journal › Article